Anti-PAD4 antibodies can suppress or augment the enzymes’ activity, reducing or enhancing the inflammatory burden [18,19] and destroying nearby organs—most reports of Anti-PAD4 antibodies are in RA. The gene discussed is PADI4; the disease is rheumatoid arthritis.